1. Home
  2. ACLS vs RDY Comparison

ACLS vs RDY Comparison

Compare ACLS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLS
  • RDY
  • Stock Information
  • Founded
  • ACLS 1995
  • RDY 1984
  • Country
  • ACLS United States
  • RDY India
  • Employees
  • ACLS N/A
  • RDY N/A
  • Industry
  • ACLS Industrial Machinery/Components
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACLS Technology
  • RDY Health Care
  • Exchange
  • ACLS Nasdaq
  • RDY Nasdaq
  • Market Cap
  • ACLS 2.1B
  • RDY 2.1B
  • IPO Year
  • ACLS 2000
  • RDY N/A
  • Fundamental
  • Price
  • ACLS $69.69
  • RDY $15.05
  • Analyst Decision
  • ACLS Buy
  • RDY Strong Buy
  • Analyst Count
  • ACLS 7
  • RDY 2
  • Target Price
  • ACLS $138.00
  • RDY $16.95
  • AVG Volume (30 Days)
  • ACLS 664.1K
  • RDY 1.7M
  • Earning Date
  • ACLS 07-30-2025
  • RDY 07-28-2025
  • Dividend Yield
  • ACLS N/A
  • RDY 0.54%
  • EPS Growth
  • ACLS N/A
  • RDY 1.47
  • EPS
  • ACLS 5.46
  • RDY 0.79
  • Revenue
  • ACLS $958,056,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • ACLS N/A
  • RDY $10.24
  • Revenue Next Year
  • ACLS $7.62
  • RDY N/A
  • P/E Ratio
  • ACLS $12.77
  • RDY $18.82
  • Revenue Growth
  • ACLS N/A
  • RDY 16.61
  • 52 Week Low
  • ACLS $40.40
  • RDY $12.26
  • 52 Week High
  • ACLS $158.61
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • ACLS 61.23
  • RDY 57.95
  • Support Level
  • ACLS $68.33
  • RDY $15.12
  • Resistance Level
  • ACLS $72.40
  • RDY $15.71
  • Average True Range (ATR)
  • ACLS 2.77
  • RDY 0.19
  • MACD
  • ACLS -0.02
  • RDY -0.07
  • Stochastic Oscillator
  • ACLS 58.32
  • RDY 31.90

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: